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SHORT COMMUNICATION
Changes in human dendritic cell number and function in severe
obesity may contribute to increased susceptibility to viral infection
D O’Shea1,2, M Corrigan1, MR Dunne3, R Jackson4, C Woods1,2, G Gaoatswe1,2, PN Moynagh4, J O’Connell1,2 and AE Hogan1,3
Dendritic cells (DCs) are key immune sentinels linking the innate and adaptive immune systems. DCs recognise danger signals and
initiate T-cell tolerance, memory and polarisation. They are critical cells in responding to a viral illness. Obese individuals have been
shown to have an impaired response to vaccinations against virally mediated conditions and to have an increased susceptibility
to multi-organ failure in response to viral illness. We investigated if DCs are altered in an obese cohort (mean body mass index
51.7±7.3 kgm 2), ultimately resulting in differential T-cell responses. Circulating DCs were found to be significantly decreased in
the obese compared with the lean cohort (0.82% vs 2.53%). Following Toll-like receptor stimulation, compared with lean controls,
DCs generated from the obese cohort upregulated significantly less CD83 (40% vs 17% mean fluorescence intensity), a molecule
implicated in the elicitation of T-cell responses, particularly viral responses. Obese DCs produced twofold more of the
immunosuppressive cytokine interleukin (IL)-10 than lean controls, and in turn stimulated fourfold more IL-4-production from
allogenic naive T cells. We conclude that obesity negatively impacts the ability of DCs to mature and elicit appropriate T-cell
responses to a general stimulus. This may contribute to the increased susceptibility to viral infection observed in severe obesity.
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INTRODUCTION
Obese persons are at risk of a diverse range of comorbid condi-
tions such as type 2 diabetes, dyslipidaemia and cardiovascular
disease. There is also an increasing body of literature describing
chronic low-grade inflammation and significant immune dysregu-
lation.1,2 Impaired immune responses lead to an increased
susceptibility to infection, although the underlying mechanisms
remain unclear. Epidemiological studies have found increased
rates of sepsis, pneumonia and wound infections in obese
inpatients.3 Obesity appears to confer an inadequate immune
response to vaccination against viral conditions in mice4 and
humans,5,6 and an increased susceptibility to overwhelming sepsis
following viral illness.7,8 Severe obesity was considered an
independent risk factor for the severity and mortality of H1N1
influenza infection.7
Myeloid dendritic cells (DCs) have been described as the
conductors of the immune system, orchestrating carefully phased
responses to microbial, cancer and vaccine antigen stimuli. They
reside as antigen-capturing cells in peripheral tissues and respond
rapidly to inflammatory cytokines and microbial products. Once they
have acquired and processed foreign antigens, they initiate an
adaptive immune response by stimulation of T cells and B cells.
Depending on the pattern of cytokine secretion, DCs are further
capable of differentially polarising the T-cell response along the Th1/
pro-inflammatory (interleukin (IL)-12) or Th2/immunosuppressive
(IL-10) pathways. On account of evidence that DCs are the most
effective antigen-presenting cell for stimulation of T-cell responses to
a range of viruses, and considering their prime location at mucosal
sites, DCs are considered to be the major players in initiation of the
primary antiviral immune response.9 Similarly, they are central to
the induction of vaccine responses, as they are the only antigen-
presenting cell that can stimulate naive T cells to differentiate to
‘experienced’ memory T cells.
The impact of obesity on myeloid DC number and function,10–12
and associated viral responses,13,14 has been described in several
reports to date. The aim of this study was to further examine the
effect of obesity on human DC function and T-cell instruction.
MATERIALS AND METHODS
Preparation of peripheral blood mononuclear cell and myeloid
DCs
Peripheral blood mononuclear cells were isolated by density centrifuga-
tion. CD14þ monocytes were magnetically isolated from peripheral blood
mononuclear cells according to the protocol described by Miltenyi Biotech
separation systems (Surrey, UK). Innate myeloid DCs were generated by
culturing CD14þ cells for 6 days in RPMI supplemented with 10% fetal
bovine serum (Hyclone, Hampton, NH, USA), 50 ngml 1 granulocyte-
macrophage colony-stimulating factor and 70 ngml 1 IL-4 (Immunotools,
Friesoythe, Germany). Supplemented medium was replenished on day 3
and DCs were harvested on day 6.
Flow cytometric analysis
Circulating DC enumeration was performed by staining peripheral blood
mononuclear cells with lineage cocktail, CD11c and HLA-DR (BD
Bioscience, Oxford, UK). Cultured DCs were analysed using a FACSCalibur
flow cytometer and CellQuest Pro software (BD Bioscience). Cells were
gated (‘monogate’) by their density and granularity. Results are expressed
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as a percentage of the monogate or the percentage/fold change in mean
fluorescence intensity.
Effect of obesity on DC function
DCs from either obese or lean donors were cultured in the absence or
presence of 10 ngml 1 lipopolysaccharide (LPS) or poly I:C for 24 h. DCs
were stained for phenotypic analysis with mAbs specific for the surface
molecules CD83 and CD86 (BD Bioscience) and relevant controls. Surface
marker expression was expressed as fold increase over DCs cultured in
medium alone. Cell supernatants were assessed by enzyme-linked
immunosorbent assay and FlowCytomix for cytokine secretion. Cytokine
levels are expressed as fold increase in production over the levels
produced by DCs cultured in media alone.
Measurement of cAMP response element-binding protein (CREB)
phosphorylation
Monocyte-derived DCs generated from either lean or obese subjects
(3 106) were cultured with or without LPS (100 ngml 1) for indicated
times. Cell lysates were generated and were then resolved by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis, transferred to nitro-
cellulose membrane and probed for immunoreactivity using anti-phospho-
CREB (Santa Cruz, Dallas, TX, USA), -CREB (Santa Cruz) and -b-actin (Sigma,
Wicklow, Ireland) specific antibodies. Immunoreactive bands were
detected using the Odyssey Infrared Imaging System (LI-COR Biosciences,
Lincoln, NE, USA) according to the manufacturer’s instructions. Densito-
metry was assessed using ImageJ software (National Institute of Health,
Bethesda, MD, USA).
T-cell cytokine production assay
Immature DCs (2 105/250ml) from obese and lean donors were cultured
with or without LPS for 24 h. After 24 h, immature DCs were co-cultured
with freshly isolated lean healthy CD3þ T cells at 10:1 ratio for 72 h.
Supernatants were assessed for cytokine production by enzyme-linked
immunosorbent assay.
RESULTS
Weight, body mass index and metabolic parameters of lean and
obese cohorts
Twenty grade III obese subjects were recruited from a hospital-
based weight management unit. In addition, 10 lean volunteers
were studied as a parallel control group. St Vincent’s University
Hospital Ethics Committee approved this study. Written informed
consent was obtained from every participant before the start
of any research activities.
The clinical characteristics of the study sample are detailed in
Table 1.
Number and function of circulating DCs in obesity
Obese individuals had significantly less circulating innate DCs
than lean controls (0.82% vs 2.53%, Po0.0001; Figures 1a and b).
Monocyte-derived DCs from lean but not obese subjects
upregulated the expression of CD86 in response to LPS. Obese
donors expressed significantly less CD83 than lean controls both
basally and post stimulation with either LPS or poly I:C (Figures 1c
and d). LPS or poly I:C stimulation of immature DCs from lean and
obese subjects resulted in significantly increased levels of IL-10,
however, obese DCs produced significantly higher levels of IL-10
than lean controls (Figure 1e). Obese DCs produced significantly
less IL-12 in response to poly I:C but no significant difference was
observed with LPS stimulation (Figures 1g and i). LPS stimulation
of immature DCs from obese subjects resulted in significantly
higher levels of phosphorylation of the CREB transcription factor
(Figures 1j and k). T cells co-cultured with LPS-stimulated DCs from
obese donors produced significantly higher levels of the Th2
cytokine IL-4 compared with lean controls (Figure 1l).
DISCUSSION
Obesity is known to impair the innate immune system.15,16
The impact of obesity on the cells of the adaptive immune system
has also been reported.17 DCs are the bridge between innate and
adaptive immune responses. They are responsible for activation
and polarisation of T cells, providing multiple signals that shape
the adaptive immune response.18 Here we report that DCs
generated from obese donors are significantly altered in both
cytokine production and T-cell-stimulating abilities when
compared with lean controls.
Obese DCs expressed significantly lower levels of CD86, a
molecule that provides the co-stimulation signal, which is required
for full T-cell responses. Obese DC also expressed significantly
lower levels of CD83 compared with lean DCs. CD83 is classically
described as a DC maturation marker, however, more recently it
has been implicated in T- and B-cell responses.19 Several viruses
influence CD83 expression, thereby inhibiting T-cell activation.
Herpes simplex virus-1 and human cytomegalovirus target and
deplete CD83 surface expression as an immune escape
mechanism.20,21 Reduced expression of CD83 on stimulated
obese DCs may contribute to the increased susceptibility to viral
infection and the defective response to vaccination against viruses
seen in obese individuals.5–7
Impairment of DC number and functionality has previously
been reported in murine studies. DCs from ob/ob mice showed
dysregulated cytokine responses to antigenic stimulation when
compared with lean controls.11 Diet-induced obese mice showed
altered and inefficient T-cell responses to influenza infection,
attributed to upregulation of immunosuppressive cytokines from
lung DCs.22 This study reports similar findings in severe human
obesity, demonstrating high levels of the immunosuppressive
cytokine IL-10 in response to LPS stimulation of obese DCs,
and increased phosphorylation of the immunosuppressive
transcription factor CREB. Furthermore, we show a significant
increase in the production of the Th2 cytokine IL-4 from T cells
co-cultured with obese DCs. The immunosuppressive profile of
cytokines produced by obese DCs, paired with the instruction of
T cells to produce significantly higher levels of IL-4, supports our
hypothesis that defective DCs may contribute to the increased risk
of viral infections in obesity.
Weber et al.23 reported that higher body mass index was the
single best predictor of failure to develop detectable antibodies to
hepatitis B vaccination. The antibody response to tetanus
vaccination was shown to be significantly reduced in overweight
children.24 Higher body mass index was associated with a
greater decline in antibody titres to influenza at 12 months
post-vaccination.6 However, little is known about the mechanism
underlying the adverse impact of obesity on response to
vaccination. The delicate balance of memory T-cell creation has
been described using a ‘Goldilocks model’, where memory T-cell
generation is best when the immune environment is ‘just right’.25
Table 1. Clinical characteristics of the study sample
Obese Lean
Gender (M:F) 5:15 3:7
Age (years) 39.3±11.8 33.3±7.0
Weight (kg) 143.6±26.6 76.7±23.9
BMI (kgm 2) 51.7±7.3 24.4±3.1
Fasting glucose (mmol l 1) 5.2±0.6 4.6±0.3
HbA1c (mmolmol 1) 41±4 33±1
Total cholesterol (mmol l 1) 5.3±1.1 4.2±0.9
Triglyceride (mmol l 1) 1.9±1.2 1.0±0.3
LDL-cholesterol (mmol l 1) 3.5±0.9 1.6±1.0
HDL-cholesterol (mmol l 1) 1.3±0.2 0.4±0.7
Abbreviations: BMI, body mass index; F, female; HDL, high-density
lipoprotein; M, male; LDL, low-density lipoprotein.
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We demonstrate dysregulated cytokine production and T-cell
stimulation, in the context of the chronic low-grade inflammatory
state of obesity.
Adult and childhood obesity levels are increasing worldwide.
The associated increased susceptibility to viral and bacterial
infections is already impacting on the medical, economic and
social burden of overweight and obesity. This study focused on
DCs, demonstrating reduced DC numbers, and a diminished ability
to elicit appropriate T-cell responses to a general stimulus in obese
individuals. This critical defect in the immune response may
contribute to the increased susceptibility to viral infection and the
poor vaccination response to certain viruses seen in obesity.
CONFLICT OF INTEREST
The authors declare no conflict of interest.
ACKNOWLEDGEMENTS
AEH is supported by the National Children’s Research Centre. The Obesity
Immunology Group is supported by Irish Health Research Board, NCRC and UCD
Newman Fellowship Programme.
REFERENCES
1 O’Shea D, Cawood TJ, O’Farrelly C, Lynch L. Natural killer cells in obesity: impaired
function and increased susceptibility to the effects of cigarette smoke. PLoS One
2010; 5: e8660.
2 Bories G, Caiazzo R, Derudas B, Copin C, Raverdy V, Pigeyre M et al. Impaired
alternative macrophage differentiation of peripheral blood mononuclear cells
from obese subjects. Diab Vasc Dis Res 2011; 9: 189–195.
3 Falagas ME, Kompoti M. Obesity and infection. Lancet Infect Dis 2006; 6: 438–446.
4 Kim YH, Kim JK, Kim DJ, Nam JH, Shim SM, Choi YK et al. Diet-induced obesity
dramatically reduces the efficacy of a 2009 pandemic H1N1 vaccine in a mouse
model. J Infect Dis 2012; 205: 244–251.
5 Weber DJ, Rutala WA, Samsa GP, Bradshaw SE, Lemon SM. Impaired
immunogenicity of hepatitis B vaccine in obese persons. N Engl J Med 1986; 314:
1393.
6 Sheridan PA, Paich HA, Handy J, Karlsson EA, Hudgens MG, Sammon AB et al.
Obesity is associated with impaired immune response to influenza vaccination in
humans. Int J Obes (Lond) 2011; 36: 1072–1077.
7 Fezeu L, Julia C, Henegar A, Bitu J, Hu FB, Grobbee DE et al. Obesity is associated
with higher risk of intensive care unit admission and death in influenza A (H1N1)
patients: a systematic review and meta-analysis. Obes Rev 2011; 12: 653–659.
8 Kwong JC, Campitelli MA, Rosella LC. Obesity and respiratory hospitalizations
during influenza seasons in Ontario, Canada: a cohort study. Clin Infect Dis 2011;
53: 413–421.
9 Klagge IM, Schneider-Schaulies S. Virus interactions with dendritic cells. J Gen Virol
1999; 80(Pt 4): 823–833.
0
10
20
30
40
50 *
**
ns
*
0
1000
2000
3000
4000
IL
-4
 c
on
c.
 p
g/
m
l **
CD11c
H
LA
-D
R
obese non obese
obese non obese Obese
NT
Non obese
NT
CD
83
 %
 M
FI
0
20
40
60
80 ***
ns
*
*
CD
83
 %
 M
FI
Non obese Obese
ObeseNon obese
NT
Obese
NT
Non obese
Lean DC
Obese DC
LPS
T cells
+
-
+
+
-
+
+
+
ObeseNon obese
NT
CD
86
 %
 M
FI
0
50
100
150
IL
-1
0 
pg
/m
l
***
*
0
5
10
15
20
500
1000
1500
IL
-1
2 
pg
/m
l
**
*
Non obese Obese
Non obese Obese
NT
LPS - + - +
Obese Lean
pCREB
CREB
-actin
NT LP
S
0.0
0.5
1.0
1.5
2.0
2.5
Obese
Lean
R
el
at
iv
e 
p-
CR
EB
 L
ev
el
s **
ns
-
-
-
+
20
5
4
3
2
1
Fo
ld
 in
cr
ea
se
 IL
-1
0
0
***
15
10
5
0
ns
40 3
ns
*** **
2
1
Fo
ld
 in
cr
ea
se
 IL
-1
2
0
30
20
10
0
ns
***
*
*
**
%
 L
in
 -,
 C
D1
1c
+,
 H
LA
-D
R+
LPS LPS NT Poly I:C NT Poly I:C
LPS NT LPS LPS NT LPS LPSNT LPS Poly I:CNT Poly I:C
Poly I:CNT Poly I:CNT
Figure 1. Obesity impairs DC cytokine production and T-cell instruction. (a) Circulating DCs were identified by electronically gating on lineage 1
negative and CD11cþ , human leukocyte antigen (HLA)-DRþ cells as shown in representative dot plots from obese and non-obese subjects. (b)
Scatter plot showing the mean DC number in obese and non-obese cohorts (n¼ 12). (c, d) Bar graphs showing the mean fluorescence intensity
expression of CD83 by non-obese and obese myeloid DCs either unstimulated or stimulated with 10ngml 1 of LPS or poly I:C for 24h. (e) Bar
graphs showing the mean fluorescence intensity expression of CD86 by non-obese and obese myeloid DCs either unstimulated or stimulated
with 10ngml 1 of LPS for 24h. (f, g) Bar graphs showing production of IL-10 and IL-12 by non-obese and obese DCs either unstimulated or
stimulated with 10ngml 1 of LPS for 24h. (h, i) Bar graphs showing production of IL-10 and IL-12 by non-obese and obese DCs either
unstimulated or stimulated with 10ngml 1 of poly I:C for 24h. (j) Western blot showing the induction of phosphorylation of CREB post-LPS
stimulation in obese and non-obese DCs. (k) Densitometry bar graph showing relative fold increase in LPS-induced phosphorylation of CREB in
obese and non-obese DCs. (l) Bar graph showing production of IL-4 by allogeneic peripheral T cells from non-obese healthy donors instructed by
DCs generated from either obese or non-obese subjects stimulated with 10ngml 1 LPS for 24h. Supernatant cytokines measured by enzyme-
linked immunosorbent assay. *P¼ 0.05, **P¼ 0.01, ***P¼ 0.001. MFI, mean fluorescence intensity; NS, not significant; NT, no treatment.
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